CCA
ACOR
Canyon Capital Advisors’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-1,193,988
| Closed | -$357K | – | 42 |
|
2022
Q3 | $357K | Hold |
1,193,988
| – | – | 0.04% | 20 |
|
2022
Q2 | $556K | Buy |
1,193,988
+544,957
| +84% | +$254K | 0.04% | 21 |
|
2022
Q1 | $1.05M | Hold |
649,031
| – | – | 0.04% | 55 |
|
2021
Q4 | $1.55M | Buy |
649,031
+256,127
| +65% | +$612K | 0.05% | 75 |
|
2021
Q3 | $1.81M | Hold |
392,904
| – | – | 0.06% | 80 |
|
2021
Q2 | $1.87M | Buy |
392,904
+196,534
| +100% | +$937K | 0.07% | 71 |
|
2021
Q1 | $956K | Buy |
+196,370
| New | +$956K | 0.04% | 75 |
|